Skip to main content

FDA Approvals

FDA Authorizes Updated COVID-19 Vaccine Formulations for Better Protection Against Current Variants

Bosulif Now FDA Approved for Pediatric Patients With Chronic Myelogenous Leukemia

FDA Approvals, Infectious Diseases

FDA Approved Abrysvo, First RSV Vaccine for Immunizing Pregnant Women, as Prophylaxis Against RSV Infection in Infants

FDA Approvals, Multiple Sclerosis

Tyruko First Biosimilar for the Treatment of Relapsing Forms of Multiple Sclerosis

FDA Approved Aphexda, in Combination With Filgrastim, to Mobilize Stem Cells for Transplant in Patients With Multiple Myeloma

Temodar Receives FDA Approval for New and Updated Indications and Doses Through the Project Renewal Program

Ojjaara FDA Approved for Treatment of Myelofibrosis and Anemia

Exxua, a First-in-Class Oral Selective 5-HT1A Receptor Agonist, FDA Approved for Major Depressive Disorder

FDA Approves Pombiliti Plus Opfolda for Treatment of Pompe Disease

Tofidence, First Biosimilar to Actemra, FDA Approved for Rheumatoid Arthritis and 2 Forms of Juvenile Idiopathic Arthritis

Page 3 of 53
Results 21 - 30 of 522